CHEM-X-INFINITY partnered with XANCHEM to produce libraries around original scaffolds. The compounds will be of particular interest in the oncology field.
CHEM-X-INFINITY partnered with ORIBASE PHARMA to offer kinase focused libraries. The compounds are built around several small aza-heterocycles underused in combinatorial libraries and will have...
CHEM-X-INFINITY is pleased to announce the release of its first libraries. The libraries have applications for several medicinal targets including kinases and GPCRs. A fragment library is added for fragment-based drug discovery.